Immunohistochemical studies have demonstrated that RAGE levels are diminished in AD patients and that some of its ligands, such as AGEs, S100, and Aβ, lead to RAGE overexpression in neurons, microglia, astrocytes, and BBB vasculature [166,183,184,185,186]. Here, AGER is linked to Alzheimer disease.